National and Kapodistrian University of Athens
Μελέτη του υποπληθυσμού των ΝΚ-T(CD3+CD56+), των ΝΚ(CD3-CD56+) και άλλων υποπληθυσμών Τ λεμφοκυττάρων με τη μέθοδο της κυτταρομετρίας ροής σε άτομα με ψωρίαση πριν και μετά τη θεραπεία με ΝΒ–UVB ακτινοβολία
Abstract
dc:descriptionPsoriasis is a chronic inflammatory T-lymphocyte-mediated cutaneous disease .The objectives of the present study were to evaluate the efficacy of NB-UVB phototherapy in the treatment of patients with active chronic plaque psoriasis as well as to examine the effect of NB-UVB phototherapy on peripheral blood levels of various T-lymphocyte subpopulations (CD3+, CD4+, CD8+ T lymphocytes, natural killer/T (NK/T) cells (CD3+CD16+, CD3+CD56+ or CD3+CD16+CD56+), natural killer (NK) cells (CD3-CD16+, CD3-CD56+ or CD3-CD16+CD56+), CD3+CLA+ [CLA=Cutaneous lymphocyte-associated antigen], CD3+CD8+CLA+, CD3+CD4+CD25+ and CD3+CD8+CD25+ T lymphocytes) in these patients A third study objective was to examine whether the potential alterations in peripheral blood levels of the above-mentioned T-lymphocyte subpopulations after NB-UVB phototherapy in patients with active chronic plaque psoriasis could be used as therapeutic outcome measures and immunological parameters for assessing the efficacy of NB-UVB phototherapy. All study participants, Caucasian volunteers ≥18 years, signed an informed consent form, and ethical approval was obtained from the Ethics and ResearchCommittee, Medical School, University of Athens, Greece. The test group included 20 untreated patients (12 males and eight females; age range 20-72 years; mean age 43.95 ± 15.46 years) with a clinical diagnosis of active chronic plaque psoriasis, while the control group comprised 10 individuals (one male and nine females; age range 33-65 years; mean age 43.80 ± 12.96 years) without active or past psoriasis. Patients in the test group were treated with NB-UVB phototherapy during the first post-sampling week and for three days weekly throughout four weeks. In conclusion, the present study confirms that NB-UVB phototherapy is a clinically efficacious therapeutic modality for psoriasis. NB-UVB phototherapy seems to be associated with a significant increase in peripheral blood levels of CD3+CD4+CD25+ T lymphocytes and with a decrease in NK cell subpopulation. More studies should be conducted in order to examine these subpopulations in peripheral blood and skin biopsies at the same time. In the future the reported alterations in peripheral blood levels could be used as therapeutic outcome measures for assessing the efficacy of NB-UVB phototherapy
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papagiannaki, Konstantina
- Παπαγιαννάκη, Κωνσταντίνα
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42056